Journal of Comprehensive Pediatrics

Published by: Kowsar

Serological Response to Measles Revaccination in a Small Population After a Mass Measles Revaccination Program

Fariba Shirvani 1 , 3 , * , Parviz Tabatabaee 2 , Reza Shiari 1 , 3 , Farideh Shiwa 1 , 3 and Mohamad Soltanzadeh 1
Authors Information
1 Department of Pediatrics, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Pediatrics, Tehran University of Medical Sciences, Tehran, IR Iran
3 Pediatric Infectious Research Center (PIRC), Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: August 01, 2012, 3 (1); 7-11
  • Published Online: August 14, 2012
  • Article Type: Research Article
  • Received: September 10, 2011
  • Revised: September 30, 2011
  • Accepted: October 10, 2011
  • DOI: 10.17795/compreped-7144

To Cite: Shirvani F, Tabatabaee P, Shiari R, Shiwa F, Soltanzadeh M. Serological Response to Measles Revaccination in a Small Population After a Mass Measles Revaccination Program, J Compr Ped. 2012 ; 3(1):7-11. doi: 10.17795/compreped-7144.

Abstract
Copyright © 2012, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis. 2001; 184(7): 817-26[DOI][PubMed]
  • 2. Omer MIA. Measles: a disease that has to be eradicated. Ann Trop Paediatr. 1999; 19(2): 125-34[DOI]
  • 3. Ghorban G, Ahmadi K, Rajai M, Hosseinzadeh SM. [Antimeasles antibody status in Sepah Pasdaran soldiers (Tehran-Iran)]. Majale Tebe Nezami. 2003; 3(5): 177-81
  • 4. Nigatu W, Samuel D, Cohen B, Cumberland P, Lemma , Brown DW, et al. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys. Vaccine. 2008; 26(37): 4769-74[DOI][PubMed]
  • 5. Fars News Agency . [A report about communicable diseases in Iran].
  • 6. Nategh R, Ebrahimpour S. [Estimation of immunity to rubella in women 18 to 25 years old and children 2 to 12 years old in eastern Azerbaijan]. Med J Tabriz Univ Med Scie. 1986; 19: 27-39
  • 7. Karimi A, Arjmandi A, Alborzi A, Rasouli M, Kadivar M. [Measles antibody in different age groups of children in shiraz (2000-2001)]. Iran J Infect Dis Trop Med. 2002; 7(18): 7-11
  • 8. Mokhtari Azad T, Mahmoodi M, Hamkar R. [Epidemiologic features of measles in Iran]. Hakim Res J. 2000; : 19-26
  • 9. Behjati M, Ayatollahi J, Karimi M, Tabatabaei F, Ghadiri A. [Epidemiologic feature of measles in Yazd province, 1995-96]. Hakim Res J. 2003; 6: 29-34
  • 10. Ghorbani GH, Joneidi N, Ahmadi K. [Immunity situation of measles and its relation with education in soldiers of Iran Pasdaran Arm Forces in 2002-2003]. Scientific and Research Journal of Islamic Republic of Iran Arm Forces. 2003; 1(4): 227-30
  • 11. Weigle KA, Murphy MD, Brunell PA. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol. 1984; 19(3): 376-9[PubMed]
  • 12. van den Hof S, van Gageldonk-Lafeber AB, van Binnendijk RS, van Gageldonk PG, Berbers GA. Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay. Vaccine. 2003; 21(27-30): 4210-4[DOI]
  • 13. Heberling RL, Kalter SS. Rapid dot-immunobinding assay on nitrocellulose for viral antibodies. J Clin Microbiol. 1986; 23(1): 109-13[PubMed]
  • 14. Whittle HC, Aaby P, Samb B, Jensen H, Bennett J, Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet. 1999; 353(9147): 98-102[DOI]
  • 15. Pannuti CS, Morello RJ, Moraes JC, Curti SP, Afonso AM, Camargo MC, et al. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic. Clin Diagn Lab Immunol. 2001; 11(1): 119-22[PubMed]
  • 16. Tischer A, Santibanez S, Siedler A, Heider A, Hengel H. Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003. 2004; 31(3): 167-78[DOI][PubMed]
  • 17. McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH. Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis. 2007; 196(10): 1459-64[DOI][PubMed]
  • 18. Manikkavasagan G, Ramsay M. Protecting infants against measles in England and Wales: a review. Arch Dis Child. 2009; 94(9): 681-5[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments